2019 EARLY CONFIRMED SPEAKERS

  • Dr Gregory A. Poland , Director of Mayo Vaccine Research Group, Mayo Clinic

  • Dr John R. Mascola , Director of the Dale and Betty Bumpers Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health

  • Michael Nally , President, Merck Vaccines  

  • Nicole Lurie , Strategic Advisor to CEO, CEPI  

  • Julia Spencer , Executive Director, Global Vaccines Public Policy, Merck 

  • Dr Vasee Moorthy , Team Leader, Vaccine Development, WHO  

  • Prof Dame Sally Davies , CMO of England

  • Dr Cyril Gay , National Program Leader, ARS, USDA

  • Wayne Koff , CEO, Human Vaccine Project

  • Dr Paul Offit , Chief Division of Infectious Diseases & Director of the Vaccine Education Center, Children’s Hospital of Philadelphia; Perelman School of Medicine at University of Pennsylvania 

  • Dr Stanley Plotkin , Emeritus Professor, University of Pennsylvania School of Medicine

  • Prof Bali Pulendran , Dpt of Pathology, Microbiology & Immunology, Stanford University School of Medicine

  • Dr Bette Tina Marie Korber , Laboratory Fellow, Los Alamos National Laboratory 

  • Dr Vu L. Truong , Founder, Chief Executive Officer, and Director, Aridis

  • Dr Arthur Reingold , Professor and Division Head Epidemiology, Former ACIP Member, UC Berkley School of Public Health

  • Arnaud Didierlaurent , Senior Director-Head of Adjuvant platform, GSK Vaccines

  • Dr Carl R. Alving , Emeritus Senior Scientist, Former Chief, Laboratory of Adjuvant & Antigen Research, U.S. Military HIV Research Program, Walter Reed Army Institute of Research

  • Dr Timothy Cooke , CEO, NovaDigm, Therapeutics & Biotechnology Representative, US National Vaccine Advisory Committee

  • Matthew Hepburn , Program Manager, DARPA 

  • Dr Eric Espeland , Chief, Vaccine Countermeasures, BARDA

  • Julie Ake, Walter Reed institute

  • Dr Ofer Levy , Staff Physician & Principal Investigator, Director, Precision Vaccines Program

  • Dr Derek O'Hagan , Global Head of Discovery Support and New Technology, GSK Vaccines

  • Arturo Casadevall , Chairman of Molecular Microbiology and Immunology, John Hopkins Bloomberg School of Public Health

  • David Mantus , Managing Director, Arsanis Biosciences GmbH

  • Dr Galit Alter , Associate Professor in Medicine, Principle Investigator, Harvard Medical School

  • Mark Esser , Senior Director, Vaccines and Infectious diseases – Translational Medicine, Medimmune

  • Mike Watson , SVP Vaccine Partnerships & Health Impact, Moderna Therapeutics

  • Dr Darrell J. Irvine , Professor of Materials Science & Engineering and Biological Engineering, MIT

  • Dr Derek O'Hagan , Global Head of Discovery Support and New Technology, GSK Vaccines

  • Dr Peter H. Khoury , President & CEO, Ology Bioservices

  • Dr Gerald Pier , Professor of Medicine (Microbiology and Immunobiology), Harvard Medical School 

  • Dr Roy Baynes , SVP, and Head Global Clinical Development, CMO, Merck Research Laboratories

  • Dr Douglas McNeel , CMO, Madison Vaccines Incorporated

  • Dr Michael Kalos , Vice President, Immuno-Oncology and Cell Therapies, Janssen

  • Dr Hari Pujar , Vice President Technical Development and Manufacturing, Moderna Therapeutics

  • Dr Pramod Srivastava , Professor Immunology and Medicine, Director of Carole & Ray Neag Comprehensive Cancer Center  University of Connecticut School of Medicine‚Äč

  • Larry Zeitlin , President, Mapp Biopharmaceutical, Inc

  • Dr Javad Aman , President and CSO, Integrated BioTherapeutics, Inc

  • Shahram Lavasani , Founder and CEO, ImmuneBiotech

  • Sonia Timberlake , VP Research, Finch Therapeutics

  • Dr Wolfgang Lietner , Chief, Innate Immunity Section, NIH   

  • Dr Bob Seder , Chief, Cellular Immunology Section, NIH Jerome Kim, Director General, International Vaccine Institute (IVI)

  • Dr Gregory M. Glenn , MD, President Research and Development, Novavax

  • Dr Bruce Gellin , President of Global Immunization, Sabin Institute

  • Angela Shen , Former Senior Science Policy Advisor, US dpt of Health, HHS

  • Dr Barney Graham , Deputy Director of Vaccine Research Center, National Institute of Allergy and Infectious Diseases

  • Dr Walter A Orenstein , Professor and Associate Director, Emory Vaccine Center Emory University

  • Dr Peter Hotez , Dean of National School of Tropical Medicine, Baylor College of Medicine

  • Dr Duane J Gubler , Emeritus Professor, Programme in Emerging Infectious Diseases, Duke-NUS Medical School

  • Dr Brad Gessner , VP of Scientific Director, Association pour la Médicine Préventive (AMP), Faculty at University Maryland/Centers for Vaccine Development & VP and Director of Global Pneumococcal Vaccines, Pfizer

  • Dr Mahesh Kumar , Vice President, Global Biologics Research, Zoetis 

  • Dr Volker Gerdts , Associate Director of Research, VIDO-InterVac

  • Barry Eisenstein , Chair, Scientific Advisory Board, Carb-X

  • Roman Chicz , Gloab Head of External Research and Development, Sanofi Pasteur

  • Mark Parrington , Senior director and Head of External R&D, Sanofi

  • Jeff Ulmer , Head, Preclinical US R&D, GSK 

  • Barney Graham , Deputy Director of Vaccine Research Centre, National Institute of Allergy and Infectious Diseases  

  • Stephen Nagler , Executive Director, MedPro Investors LLC 

  • Dr Peter Hotez , Dean, National School of Tropical Medicine, Director, Texas Children’s Hospital Centre

  • Dr Sean Tucker , CSO, Vaxart, Inc.

  • Darin Zehrung , Program Advisor and Portfolio Leader of the Vaccine and Pharmaceutical Delivery Technologies, PATH

  • Dr Samuel Rabkin , Thomas A. Pappas Professor of Neurosciences, Department of Neurosurgery (Microbiology & Immunology), Massachusetts General Hospital and Harvard Medical School

  • Dr Saad Omer , Professor, Emory Vaccine Center; Global Health, Epidemiology, and Pediatrics; Emory University, Schools of Public Health & Medicine, Emory Vaccine Center, Emory University

  • Dr Dan Salmon , Prof Global Disease Epidemiology and Control; Deputy Director, JHU’s Institute for Vaccine Safety; Johns Hopkins Bloomberg School of Public Health

  • Dr Ed Lewin , Adjunct Professor of Pediatrics,  Milken Institute for Public Health, Georgetown University School of Medicine

  • Charles Heffernan , Former Supply Chain Transformation and Technology Innovation Lead, GSK & Member of BioPhorum Operations Group, BPOG

  • Senior representative, PharmOlam

  • Senior representative, Marken

  • Senior representative, Paragon

  • Senior representative, Syneos Health

  • Senior representative, Kerry

  • Senior representative, ICON

  • Senior representative, ExpreS2ion

  • Senior representative, GE Healthcare

  • Senior representative, hVIVO

  • Senior representative, UTMB Sealy Centre

  • Senior representative, Sergeant Adjuvants

  • Senior representative, Batavia

  • Senior representative, Intravacc

 
APPLY TO SPEAK

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071